Calcitonin gene-related peptide (CGRP) is a widely expressed neuropeptide that has a major role in sensory neurotransmission. The CGRP receptor is a heterodimer of the calcitonin receptor-like receptor (CLR) class B G-proteincoupled receptor and a type 1 transmembrane domain protein, receptor activity-modifying protein 1 (RAMP1). Here we report the structure of the human CGRP receptor in complex with CGRP and the G s -protein heterotrimer at 3.3 Å global resolution, determined by Volta phase-plate cryo-electron microscopy. The receptor activity-modifying protein transmembrane domain sits at the interface between transmembrane domains 3, 4 and 5 of CLR, and stabilizes CLR extracellular loop 2. RAMP1 makes only limited direct contact with CGRP, consistent with its function in allosteric modulation of CLR. Molecular dynamics simulations indicate that RAMP1 provides stability to the receptor complex, particularly in the positioning of the extracellular domain of CLR. This work provides insights into the control of G-protein-coupled receptor function. 4 9 2 | N A t U r e | V O l 5 6 1 | 2 7 S e P t e M B e r 2 0 1 8
CGRP is a physiologically important sensory neuropeptide with roles that include modulation of metabolism, inflammatory response and blood pressure, as well as auditory nerve development and function [1] [2] [3] [4] . It is a potent vasodilator that is released during neurogenic inflammation and contributes to the pathology of migraine. A first-in-class drug targeting the CGRP receptor was recently approved for treatment of this condition, and many other therapeutic agents aimed at reducing CGRP activity are under development 5 . By contrast, CGRP is protective in models of inflammatory bowel disease and hypertension, and is a critical neuropeptide for development and modulation of auditory responses [1] [2] [3] [4] .
Receptor activity-modifying proteins (RAMPs) are essential accessory proteins for presentation of the class B CLR to the cell surface. They are integral components of the phenotypically ascribed CGRP and adrenomedullin receptors, through which CLR-RAMP1 mediates a selective response to CGRP, and CLR-RAMP2 or CLR-RAMP3 mediate selective responses to adrenomedullin 6 . RAMPs are also partners for the calcitonin receptor (CTR), but are not required for cell surface trafficking; they generate distinct amylin receptor phenotypes 1 . There is considerable crosstalk between calcitonin-family peptides and receptors; however, research has largely focused on how RAMPs influence cAMP signalling 1 . The three RAMPs each contain a structured, N-terminal extracellular domain (ECD) of about 100 amino acids, a single transmembrane domain and a short intracellular C terminus. There is evidence that RAMPs co-evolved with GPCRs 7 ; supporting this, we and others have shown that they can partner with numerous GPCRs from all major subclasses, and are not exclusively partners for CLR and CTR [8] [9] [10] [11] .
Structures of heteromeric complexes of the isolated extracellular domains (ECDs) of RAMPs and CLR bound to C-terminal peptide fragments have been solved 12, 13 , and provide important but limited data on how RAMPs and CLR interact; however, they are unable to explain peptide selectivity. Therefore, structures of full-length, active CGRP and adrenomedullin receptor complexes are required.
Recent advances in cryo-electron microscopy (cryo-EM) have enabled elucidation of structures of full-length, class B GPCRs bound to peptide agonists, in complex with their canonical G s -protein heterotrimers [14] [15] [16] . These studies revealed class-specific, conserved, global conformational changes linked to receptor activation, and unexpected divergence in the modes of peptide binding, even within the same receptor [14] [15] [16] [17] [18] . In the current work, we have used Volta phase-plate cryo-EM to determine the structure-at a global resolution of 3.3 Å-of the human CGRP receptor complex bound to its endogenous peptide agonist and canonical transducer. This structure provides insights into how RAMPs interact with GPCRs and modulate their activity.
Structure determination
We modified the CLR to replace the native signal peptide with that of haemagglutinin and affinity tags bracketed by 3C cleavage sites were introduced at the N and C terminus (Flag and His, respectively) (Extended Data Fig. 1 ). RAMP1 was modified with a haemagglutinin signal peptide followed by a Flag epitope (Extended Data Fig. 1 ). These modifications did not alter the receptor pharmacology (Extended Data Fig. 2a ).
To form an active, G-protein-coupled complex, CLR and RAMP1 were co-expressed with Gα s , His-Gβ 1 and Gγ 2 in Trichoplusia ni insect cells, and stimulated with 10 μM CGRP. A stabilized Gα s 15 was used together with the camelid antibody-derived nanobody Nb35 [14] [15] [16] , enabling formation of a complex with improved stability 19 . The complex was treated with 3C enzyme to remove tags from CLR, solubilized in lauryl maltose neopentyl glycol (LMNG) and cholesteryl hemisuccinate and then purified by sequential nickel-affinity and
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Flag-antibody columns, to ensure that only RAMP1-bound complexes were present, and then further purified by size-exclusion chromatography to yield a monodisperse complex that contained all the components (Extended Data Fig. 2b, c) .
Vitrified complexes were imaged using a Titan Krios microscope equipped with a Volta phase plate 20, 21 . Following imaging (Extended Data Fig. 3a ) and initial 2D classification (Extended Data Fig. 3b ), 3D classification yielded a final map at a resolution of 3.3 Å reconstructed from 407,000 particle projections ( Fig. 1a , Extended Data Fig. 3c -e, Supplementary Table 1 ). The cryo-EM density map exhibited wellresolved side chains, allowing confident rotamer placements for most amino acids within the peptide, receptor and RAMP transmembrane domains, and the G protein (Extended Data Fig. 4 ). The RAMP and CLR ECDs had lower overall resolution, with discontinuous density for CLR ECD loop 1 and loop 5 ( Fig. 1a , Extended Data Figs. 1, 5). Nonetheless, there was a strong correlation between the cryo-EM density of the ECD and those of the individual ECDs of either CLR or RAMP1 in a deposited X-ray structure (RCSB Protein Data Bank code (PDB): 4RWG 12 ). These were rigid-body fitted into the ECD density, with side-chain adjustment where this was supported by density in the cryo-EM map. Whereas individual ECDs from the X-ray structures exhibited close approximation to the cryo-EM map, there were differences between the two structures in the relative positioning of the CLR and RAMP1 ECDs (Extended Data Fig. 5 ) that are likely to have arisen from anchoring constraints of the transmembrane domains in the fulllength structure. Continuous density was observed for the RAMP1 ECD and transmembrane domain, including the unstructured linker domain, but not for the short C-terminal tail of RAMP (Thr144-Glu-Gly-Ile-Val148), indicating that it is mobile in the active receptor complex ( Fig. 1 ). There was robust density for most of the transmembrane core and loops of CLR, but not for segments of extracellular loop 3 (ECL3) and intracellular loop 3 (ICL3) ( Fig. 1, Extended Data Fig. 4 ). Additional density was observed adjacent to the base of transmembrane domain 2 (TM2) and TM4, which may represent lipid interactions with CLR (Extended Data Fig. 3g ). There was a relatively short helix 8 (H8), with no density for the C terminus of CLR beyond Y402 8.53 (receptor residues in superscript are defined using the class B numbering system 14, 22 ) or for the far N terminus of the ECD (Fig. 1 , Extended Data Fig. 1 ), indicating that these regions are also mobile. The N terminus of CGRP (A1-V23), which binds within the receptor core, was welldefined in the map, and the majority of side chains in the CGRP C terminus (F27-F37) that interact exclusively with receptor ECDs, were also supported by good density (Extended Data Fig. 4 ). Similar to salmon calcitonin (sCT) in the G s -coupled CTR 14 , there is a large kink in the peptide that enables interaction across the two receptor domains, with the CGRP linker (K24-N26) being poorly resolved in the map. Within the receptor core, side chains that had limited density were stubbed in the model (Extended Data Fig. 1 ). There was wellresolved density for the G s heterotrimer across the receptor interface and between subunits. The α-helical domain of the α-subunit was present only in a small number of the 2D class averages and was masked out during map refinement. In general, the regions of lower resolution or those lacking density were segments of the complex that exhibited higher mobility in molecular dynamics simulations of the full complex (Extended Data Fig. 6 , Supplementary Videos 1, 2).
The CLR-RAMP1 interface
The 2D class averages reveal that there is a single predominant orientation of the ECDs of the complex relative to the CLR-RAMP core (Extended Data Fig. 3b ). This is in contrast to the variability in ECD orientation observed for the CTR 14 . RAMP1 makes extensive contacts with CLR, with around 23% of its surface being buried within this interface ( Fig. 1b, c) . The extensive interface across the ECDs has been reported in X-ray crystal structures 12, 23 . In contrast to predictions in published models of RAMPs in complex with CLR or CTR [24] [25] [26] [27] , the RAMP1 transmembrane domain sits at an interface formed by TM3, TM4 and TM5 of CLR, with interactions of the upper half occurring principally with TM5 (T288 5.33/ECL2 , H289 5.34/ECL2 , I293 5.38 ) ( Fig. 2a , b) and at the base with TM3 (L231 3.48 , I235 3.52 , T239 3.56 , V243 ICL2 ) and TM4 (W254 4.44 , Y255 4.45 , L258 4.48 , F262 4.52 ) ( Fig. 2a, c) . These interactions were primarily van der Waals interactions, although there was potential for hydrogen-bond formation between Y255 4.45 and RAMP1 S141. D113 in the membrane-proximal segment of RAMP1 formed hydrogen bonds with residues in ECL2 proximal to CLR TM4 (Y278 ECL2 ) and TM5 (T288 5.33 , H289 5.34 ) ( Fig. 2b ). Alanine mutagenesis studies of CLR residues [28] [29] [30] [31] [32] [33] revealed decreased CGRP potency for the Y278 ECL2 , T288 5.33/ECL2 and W254 4.44 mutants, with no effect from H289 5.34/ECL2 , I293 5.38 , T239 3.56 , V243 ICL2 or Y255 4.45 mutants 32,33 , consistent with important but weak interactions between RAMP1 and CLR. Likewise, there was a small decrease in CGRP potency with the RAMP1(D113A) mutant, indicating an indirect effect on CGRP binding 34 . To understand the dynamics of the RAMP1-CLR interface, we performed molecular dynamics simulations, following modelling of missing amino acids and side chains into the full protein complex (Extended Data Fig. 7a , b, Supplementary Table 2 , Supplementary Video 1); these simulations confirmed the importance of interactions between RAMP1 D113 and CLR ECL2 (Extended Data Fig. 7a ). the detergent micelle has been masked out for clarity. Middle, the structure in ribbon representation after refinement in the cryo-EM map. CGRP, dark red; CLR, blue; RAMP1, dark orange; Gα s -Ras domain, gold; Gβ-subunit, cyan; Gγ-subunit, purple; Nb35, red. Right, the cryo-EM density map coloured by local resolution. b, c, CGRP receptor complex (ribbon representation coloured as in a), illustrating the extent of CLR interactions with other proteins in the complex (b), or the extent of RAMP1 interactions with other proteins in the complex (c), shown in mauve coloured surface representation. CGRP and RAMP1 form extensive contacts with CLR, with 61.5% and 23% of their surface being buried, respectively.
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The simulations also predicted that E47 ECD formed persistent hydrogen-bond interactions with RAMP1 R112, in addition to hydrogen bonds to the RAMP1 backbone (G108 and A110) in the linker region. RAMP1 R112 was also predicted to form less frequent hydrogen bonds with D90 ECD , but may maintain more persistent ionic interactions. Collectively, these interactions are likely to contribute to the limited mobility of the RAMP1 linker and stable positioning of the ECDs relative to the receptor core (Extended Data Fig. 7a , Supplementary  Table 2 , Supplementary Videos 2, 3). From the cryo-EM map, there were no resolved interactions between the RAMP and G protein; however, there was no density for the C-terminal tail of RAMP1. Molecular dynamics simulations in which the C terminus of RAMP1 was modelled predicted transient interactions with ICL2 and the αN helix of the Gα protein, with potential interactions that could extend to ICL1 (Supplementary Table 2 ); nevertheless, this segment was highly mobile in the simulations.
The CGRP-binding site
CGRP forms extensive interactions with the CLR-RAMP1 complex, with 61.5% of its surface buried. Notably, the only direct contact between the peptide and RAMP1 occurs at the far C terminus of the peptide, principally with the cluster of RAMP residues (F83-P85) that have been observed in isolated ECD structures 12 (Fig. 3a) . The N-terminal peptide loop that is constrained within CGRP (C2-C7) is deeply buried and extends into an amphipathic α-helix, up to CGRP V23, which forms extensive van der Waals interactions with CLR ( Fig. 3d ). There are only a small number of hydrogen bonds formed in the static structure between the N terminus of the peptide and the core of CLR; these include interactions between Y292 5.37 and the backbone of CGRP D3, between H295 5.40 and CGRP T6, and between S286 ECL2 and the backbone of CGRP H10 (Fig. 3c, d ). Of these, only the interaction between H295 5.40 and CGRP T6 is functionally important; the H295 5.40 A mutation cause a loss of about 30-fold in CGRP potency on cAMP accumulation 28 . The equivalent residue in CTR is H302 5.40 , which is predicted to form a hydrogen bond with T6 of sCT 14 . Alanine substitution of CGRP T6 leads to a loss of about 80-fold in peptide potency 29 , confirming the importance of this bond and other interactions. There are extensive interactions between the peptide and TM3, TM5 and ECL2 of CLR. Below H295 5.40 , a series of amino acids that includes I298 5.43 , L302 5.47 , M223 3.40 and Y227 3.44 forms the bottom of the peptide-binding pocket ( Fig. 3c, d , Extended Data Fig. 8b ). Alanine substitution of CGRP T4 leads to a more than 20-fold reduction in CGRP potency 29 . However, this residue forms only limited interactions with the receptor; side-chain-to-backbone interactions within the peptide that contribute to the loop fold and initiation of the peptide helix may underlie its functional importance. CGRP T9 and H10 pack within an extended cluster of residues that includes T191 2.64 , L195 2.68 , H219 3.36 , S286 ECL2 and I284 ECL2 (Fig. 3c , Extended Data Fig. 8b ). With the exception of S286 ECL2 , alanine mutation of these residues caused marked impairment in CGRP signalling 28, [30] [31] [32] (Extended Data Fig. 8b ), with I284 ECL2 and L195 2.68 forming a hydrophobic barrier that coincides with the exit of the peptide from the receptor core (Extended Data Fig. 8b ); molecular dynamics simulations predict transient hydrogenbond formation between CGRP T9 and H219 3.36 (Extended Data Fig. 9e , Supplementary Table 3 ). Alanine substitution of CGRP T9 causes a 15-fold loss of CGRP potency 29 , consistent with the importance of interactions with this side chain. Whereas mutations to amino acids in the distal segment of ECL2 (S286 ECL2 , D287 ECL2 , H289 ECL2 , L291 5.36 ) had relatively limited effects on CGRP potency 28 (Extended Data Fig. 8b ), ECL2 conformation is critical to CGRP activation of its receptor, with R274 4.64 A and, in particular, W283 ECL2 A mutations being highly detrimental to CGRP signalling 32 (Extended Data Fig. 8b ). These residues are critical for the stable packing of ECL2 in the active structure, similar to those observed in other active, class B GPCR structures [14] [15] [16] . There are only limited contacts between ECL1 and the peptide, the most prevalent being from CGRP L16 and S17 to A199 ECL1 , N200 ECL1 , Q202 ECL1 and V205 ECL1 (Fig. 3b , Extended Data Fig. 8b ). Q202 ECL1 is within weak hydrogen-bond distance of the backbone oxygen of CGRP S17 (Extended Data Fig. 8b ); however, alanine mutation of Q202 ECL1 , N200 ECL1 or V205 ECL1 had no effect on CGRP potency, indicating the limited importance of this domain for CGRP activity 30 . CLR and CTR have shorter ECL1 loops compared to the related glucagon receptor 35 , or glucagon-like peptide-1 receptor (GLP-1R) 15, 16 . These receptors have longer TM2 and TM3 helices (Extended Data Fig. 10a , b) that interact with the extended helix of peptide agonists of these receptors 15, 16, 35 . In the cryo-EM map, there was no high-resolution density for ECL3, consistent with only limited interaction between CGRP and this receptor segment. This high mobility and lack of persistent interactions was also observed in our molecular dynamics simulations (Extended Data Fig. 9a -f, Supplementary  Table 3 , Supplementary Video 2), whereas previous alanine mutagenesis studies also support a limited role of this domain in CGRP-mediated cAMP production 28, 30 (Extended Data Fig. 8b ).
CGRP V8, L12 and L16 are on the same face of the peptide α-helix and sit deep within a groove formed by TM1 and TM7, where they pack among multiple residues on the receptor. Alanine mutations of individual receptor amino acids within this groove have very little effect on CGRP-mediated cAMP production (Extended Data Fig. 8b ), consistent with only weak contacts being made by individual receptor amino acids. Nevertheless, alanine substitution of either CGRP L12 or L16 markedly impaired CGRP potency 36 , indicating that the packing of the hydrophobic face of the peptide helix is critical for receptor activation.
In the cryo-EM structure, CGRP R11 forms polar interactions with the backbone of CGRP T4 and C2, with potential salt-bridge interactions with CGRP D3 and D366 7.39 on the receptor, and may contribute to stability of the CGRP loop conformation (Fig. 3C ). In molecular dynamics simulations, CGRP R11 formed persistent hydrogen bonds with D366 7.39 , although these interactions are not observed in the cryo-EM map. CGRP R18 is within salt-bridge distance of D287 ECL2 and D90 ECD , and forms a hydrogen bond with D287 ECL2 in nearly 25% of frames in the simulation (Fig. 3b , Extended Data Fig. 9d, e ).
The resolutions of the peptide C terminus and receptor ECDs are lower than the resolution in the receptor core, and they were primarily modelled by rigid-body fitting of the available X-ray structure (PDB: 4RWG 12 ). To test the stability of interactions in the fully active structure, we ran 6.4-μs molecular dynamics simulations. Our data are consistent with the interactions previously reported in the isolated ECD structure 12 , and are summarized in Extended Data Fig. 9a-f and Supplementary Table 3 . The main intermolecular interactions were between CGRP T30 and D94 ECD (Fig. 3b , Extended Data Fig. 9e ), and between the amide of CGRP F37 and backbone atoms of T122 ECD (Extended Data Fig. 9e ). There were no persistent hydrogen bonds between CGRP and RAMP1. The critical importance of interactions between the C terminus of CGRP (F27-F37) and the ECDs of CLR and RAMP1 for CGRP signalling has been highlighted by previous mutagenesis studies 12, 23, 34, 37, 38 , and are illustrated in Extended Data Fig. 8a . The extent to which this is dependent upon the stability of the relative positioning of the ECD to the receptor core is unclear, but RAMP1 is a major contributor to the limited conformational flexibility of the ECD domain of CLR (Supplementary Video 3).
Comparisons with the CTR structure
CTR is most closely related to CLR, and can also interact with RAMP1 to form a high-affinity CGRP receptor 1 . Therefore, we compared the structure of the sCT-CTR-G s complex to the CGRP-receptor complex. Owing to the relatively limited resolution in the peptide-binding domain and N terminus of the CTR, comparisons were limited to the backbone structures in these regions. Overall, there was a high degree of similarity between the CLR and CTR structures, with both exhibiting an extended TM1 α-helical stalk that interconnects the receptor core and ECD, and a similar organization of the upper segments of TM6 and TM7 to accommodate the bulk of the cysteine-bridged loops of the peptides (Fig. 4a ).
The largest difference between the CTR and CLR structures was in the orientation of the ECD relative to the receptor core ( Fig. 4a, b ). This located the C terminus of the peptides at nearly equivalent positions, with the N-terminal activation domain of the peptides also occupying a similar binding cavity (Fig. 4b ). Within the receptor core, there was an inward shift of approximately 2 Å of the CLR relative to CTR at the apex of TM5, which is likely to be a result of the interaction of RAMP1 with this domain (Fig. 4c ). There is a high degree of sequence conservation between CLR and CTR among the residues that contacted the RAMP (Fig. 4d ), which may explain the similar broad specificity for RAMP interaction of these receptors. In previous simulations of the CTR bound to human CT versus sCT, there was destabilization of ECL2 for human CT relative to the sCT-bound receptor that was indicative of a role for conformational dynamics of this receptor domain in ligand interaction and efficacy 18 . The interactions of RAMP1 with ECL2 may therefore contribute to peptide selectivity and/or efficacy.
At the base of the receptor, the structured H8 of CLR was much shorter than that of CTR (Fig. 4a) , and consequently exhibited more-limited interaction with the Gβ-subunit. Nevertheless, truncation studies of the CTR C terminus indicated that only the segment that is also present in the CGRP receptor structure is functionally important for G s -mediated signalling 14 . Perhaps more relevant, although the α-helix 5 of the Ras-like domain of Gα s (Gα s -Ras) is aligned between the two structures, there are differences within the G protein, particularly with respect to the positioning of the αN helix of Gα s -Ras; these differences are propagated across the βand γ-subunits (Fig. 4e) .
Broader comparison of protein interactions of G s to include the structures of GLP-1R bound to either exendin-P5 15 Receptor transmembrane helices are numbered using roman numerals. b, Contact residues in CGRP, L15-V23; T30, which forms two hydrogen bonds with CLR D94 ECD is also shown. c, CGRP contact residues V8-G14. d, CGRP contact residues A1-C7. There are very few hydrogen bonds between the peptide N terminus and CLR in the static structure.
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(Extended Data Fig. 10a, b ) also revealed differences in the relative positioning of G s . However, this was principally due to translational differences in the engagement of the receptors and α-helix 5 (Extended Data Fig. 10c ), with strong overlap in the backbone of the Gα-subunit when these are aligned (Extended Data Fig. 10d ). ICL2 of CLR and of CTR are longer than that of GLP-1R, and there is an increase of about 2 Å in the outward movement of the base of TM6 of CLR and CTR compared to GLP-1R (Extended Data Fig. 10a ); these differences are likely to account for the translational differences in engagement of the G s protein by GLP-1R.
Stability of the complex in the absence of RAMP1
In molecular dynamics simulations of the complex in the presence and absence of RAMP1, the orientation of the ECD of CLR remains relatively stable in CLR-CGRP-RAMP1-Gαβγ-Nb35 (6.4-μs simulation) and CLR-CGRP-RAMP1-mini-Gα (2-μs simulation), but not in CLR-CGRP-mini-Gα (2-μs simulation) ( Supplementary Videos 1-3 ). In the absence of RAMP1, only CGRP and TM1-with its extension-hold the ECD in place relative to the transmembrane domain. The N-terminal region (A1-R18) of CGRP is stable (Supplementary Video 2) even in the absence of RAMP1, but the C-terminal region is affected by the mobility of the CLR ECD and is much more mobile in the absence of RAMP1 (Extended Data Fig. 6, Supplementary  Video 3) . A consequence of this C-terminal mobility in the absence of RAMP1 is reduced persistence of hydrogen bonds formed by CGRP in this region ( Supplementary Table 4 ). RAMP1 provides additional stability to ECL2, a major contact point for CGRP-though this loop is relatively stable even in the absence of RAMP1. In the simulation in the absence of RAMP1, there is a marked reduction in the persistence of hydrogen bonds between R274 4.64 and D280 ECL2 (Supplementary Table 5 ). In the cryo-EM structure, these two residues form a salt-bridge interaction, and this interaction in the presence of RAMP1 is likely to affect signal propagation. Indeed, mutagenesis of either of these residues greatly affects CGRP-mediated cAMP signalling 28, 32 . RAMP1 interaction does not affect the mobility of the distally located ECL1 and ICL3. The least mobile points of each transmembrane domain generally correspond to points of helix intersection; for TM3 this is in the vicinity of Y227 3.44 , which provides a deep stable contact point for CGRP.
Whereas these simulations provide insight into the contribution of RAMP1 to the preformed active complex, this complex does not form in the absence of RAMP1, even where CLR is present at the cell surface 6 , indicating that the CLR-RAMP1 interaction is also critical for initial peptide binding and presentation to the receptor core.
In conclusion, the structure of the CGRP-CLR-RAMP1-G s complex provides insight into the organization of functionally important heteromeric GPCR complexes. RAMP1 causes marked stabilization of the ECD of CLR, and therefore has a critical role in ligand presentation to the receptor core. It further enhances stability of the transmembrane domain interface and ECL2, which are important for propagation of peptide-induced signalling. This study provides a framework for the development of novel therapeutics that target the CGRP system.
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ig. 4 | The CTR and CGRP receptor complexes display similar backbone conformations but have distinct conformations of the Gα s -Ras domain. a,
Alignment of the CLR-RAMP1−CTR (blue, dark orange and grey ribbon, respectively) structures; for the CTR the ECD is from the X-ray structure of the sCT-CTR X-ray structure (PDB: 5II0 39 ), following rigid-body fitting to the CTR cryo-EM map 14 .
Receptor transmembrane helices are numbered using roman numerals. b, Magnified view of the peptide-binding sites. CGRP (dark red) and sCT (green) are shown as ribbon, CLR (blue) and CTR (grey) are shown as transparent ribbon. The circles highlight the similarities in position of the peptide N-(green) and C-(red) termini. RAMP1 has been omitted for clarity. c, Magnified view highlighting differences in the upper segment of TM5 (red circle). d, Overlap in RAMP1-contact residues between CLR (blue x-stick) and CTR (grey x-stick). e, The Gα s -Ras-H5 is superimposed in the two structures, but the α-H1 helix is in a different orientation (red circle) and leads to distinct positioning of the Gβ-and Gγ-subunits. The CTR G protein is shown as grey ribbon, the CGRP receptor G protein as coloured ribbon. Gα s -Ras, gold; Gβ, cyan; Gγ, dark purple. Regions of the receptor structures that are missing in the PDB files are shown as dashed lines.
Article reSeArcH

MEthodS
No statistical methods were used to predetermine sample size. The experiments were not randomized. The investigators were not blinded to allocation during experiments and outcome assessment. Constructs. CLR was modified to include an N-terminal Flag-tag epitope and a C-terminal 8× His tag; both tags are removable by 3C protease cleavage. The construct was generated in both mammalian and insect cell expression vectors. RAMP1 was modified to include an N-terminal Flag-tag epitope. For both constructs, the natural signal peptide was replaced with that of haemagglutinin to improve expression (Extended Data Fig. 1) . Expression in insect cells. CLR, RAMP1, DNGα s 15 , His 6 -tagged human Gβ1 and Gγ2 were expressed in Trichoplusia ni insect cells (Expression Systems) using baculovirus. Cell cultures were grown in ESF 921 serum-free medium (Expression Systems) to a density of 4 × 10 6 cells per ml and then infected with the three baculoviruses CLR, RAMP1, DNG αs and Gβ1γ2 at a ratio of 1:5:2:1. Culture was collected by centrifugation 48 h after infection and cell pellet was stored at −80 °C. Complex purification. Cell pellet was thawed in 20 mM HEPES pH 7.4, 50 mM NaCl, 2 mM MgCl 2 supplemented with cOmplete Protease Inhibitor Cocktail tablets (Roche). Complex formation was initiated by addition of 10 μM human αCGRP (Chinapeptide), Nb35-His (10 μg/ml), 3C protease (10 μg/ml) and apyrase (25 mU/ml, NEB); the suspension was incubated for 1 h at room temperature. Membranes were collected by centrifugation at 30,000g for 30 min. Complexes from membranes were solubilized by 0.5% (w/v) lauryl maltose neopentyl glycol (LMNG, Anatrace) supplemented with 0.03% (w/v) cholesteryl hemisuccinate (CHS, Anatrace) for 2 h at 4 °C in the presence of 1 μM CGRP and apyrase (25 mU/ml, NEB). Insoluble material was removed by centrifugation at 30,000g for 30 min and the solubilized complex was immobilized by batch binding to Ni-NTA resin. The resin was packed into a glass column and washed with 20 column volumes of 20 mM HEPES pH 7.4, 100 mM NaCl, 2 mM MgCl 2 , 0.01% (w/v) LMNG and 0.006% (w/v) CHS, 1 μM CGRP, before bound material was eluted in buffer containing 250 mM imidazole. The Ni-NTA-purified fraction was immobilized by batch binding to M1 anti-Flag affinity resin in the presence of 3 mM CaCl 2 . The resin was packed into a glass column and washed with 20 column volumes of 20 mM HEPES pH 7.4, 100 mM NaCl, 2 mM MgCl 2 , 3 mM CaCl 2 , 1 μM CGRP, 0.01% (w/v) LMNG and 0.006% (w/v) CHS before bound material was eluted in buffer containing 5 mM EGTA and 0.1 mg/ml Flag peptide. The complex was then concentrated using an Amicon Ultra Centrifugal Filter (MWCO 100 kDa) and subjected to size-exclusion chromatography on a Superose 6 Increase 10/300 column (GE Healthcare) that was pre-equilibrated with 20 mM HEPES pH 7.4, 100 mM NaCl, 2 mM MgCl 2 , 1 μM CGRP, 0.01% (w/v) LMNG and 0.006% (w/v) CHS. Eluted fractions consisting of receptor and G-protein complex were pooled and concentrated. Final yield of purified complex was approximately 0.3 mg per litre of insect cell culture. SDS-PAGE and western blot analysis. Sample collected from size-exclusion chromatography was analysed by SDS-PAGE and western blot as previously described 15 . For SDS-PAGE, precast gradient TGX gels (Bio-Rad) were used. The final elution peak from size-exclusion chromatography was stained using Instant Blue (Expedeon). Modelling into cryo-EM density. An initial template for CLR was generated by homology modelling using the cryo-EM structure of human CTR (PDB: 5UZ7) 14 , performed with the Molsoft ICM modelling software 40 . Manual adjustment and rebuilding was performed in Coot 41 . Owing to limited density in CLR and RAMP1 ECD regions, we used the high-resolution X-ray crystal structure (PDB: 4RWG) 12 for modelling. ECDs of CLR and RAMP1 were, separately, rigid-body fitted into density before the final iteration of global refinement. DNGα s , Gβ1, Gγ2 and Nb35 models were taken from the GLP1-R-G s -ExP5 structure (PDB: 6B3J) 15 . The CGRP peptide and RAMP1 transmembrane domain were modelled manually. The final model was subjected to global refinement and minimization in real space using the module 'phenix.real_space_refine' in PHENIX 42 . Validation was performed in MolProbity 43 . Preparation of vitrified specimen. Electron microscopy grids (Quantifoil, 200-mesh copper R1.2/1.3) were glow-discharged for 30 s using Harrick plasma cleaner (Harrick). Four microlitres of sample was applied on the grid in the Vitrobot Mark IV chamber (Thermo Fisher Scientific). The chamber of the Vitrobot was set to 100% humidity at 4 °C. The sample was blotted for 4.5 s with a blot force of 20 and then plunged into propane-ethane mixture (37% ethane and 63% propane). Data acquisition. Datasets were collected on a Thermo Fisher Scientific Titan Krios microscope operated at 300 kV (FEI) equipped with a Gatan Quantum energy filter, a Gatan K2 summit direct electron camera (Gatan) and a Volta phase plate (Thermo Fisher Scientific). Movies were taken in EFTEM nanoprobe mode, with 50-μm C2 aperture, at a calibrated magnification of 47170 corresponding to a magnified pixel size of 1.06 Å. Each movie comprises 50 subframes with a total dose of 50 e − per Å 2 , exposure time was 13 s with a dose rate of 4.8 e − pixel −1 s −1 on the detector. Data acquisition was done using SerialEM software at −600-nm defocus 44 . Data processing. A total of 3,180 movies were collected and subjected to motion correction using MotionCor2 45 . CTF estimation was done using Gctf software 46 on non-dose-weighted micrographs. The particles were picked using Gautomatch (http://www.mrc-lmb.cam.ac.uk/kzhang/Gautomatch/). An initial model was made using the common-line approach in EMAN2 47 , based on a few automatically picked micrographs and using the common-line approach. The particles were extracted in RELION v.2.01b1 48 using a box size of 200 pixels. A total of 1,205,000 picked particles were subjected to 2D classification with 100 classes, followed by 3D classification. After selecting the best-looking class, with 407,000 particles, 3D auto-refinement was performed in RELION v.2.01b1. The final map was sharpened with a B-factor of −50 Å 2 . The processing workflow is outlined in Extended Data Fig. 3c . Model overfitting was evaluated by randomly displacing all atoms by 0.5 Å and refined against one cryo-EM half map. Fourier shell correlation curves were calculated between the resulting model and the half map used for refinement, the resulting model and the other half map for cross validation, and the final refined model and the full map (Extended Data Fig. 3f ). Mammalian cell cAMP assays. COS-7 cells, which were confirmed to be free from mycoplasma, were transfected in suspension in 96-well plates (10,000 cells per well) with 50 ng CLR + 50 ng human RAMP1 using 600 ng polyethylenimine (PEI). The transfection was performed in DMEM with 5% FBS, 200 μl total volume per well, and cells were incubated for 48 h at 37 °C, 5% CO 2 . cAMP detection was performed as described 49 . All values were converted to cAMP concentration using a cAMP standard curve performed in parallel and data were subsequently normalized to the response to 100 μM forskolin. Conformational clustering of CGRP ECL3 and RAMP1. The missing loops throughout CLR were generated using PLOP 50 , which has been shown to be effective in generating GPCR loop conformations 51 . The missing side chains were iteratively optimized to convergence using PLOP. In addition, to enhance the conformational sampling of ECL3, which is likely to interact with the CGRP peptide, a preliminary clustering of 4,000 different loop models generated using Modeller 9.16 52 was performed by means of the Clustering VMD plugin (available at http://physiology.med.cornell.edu/ faculty/hweinstein/vmdplugins/clustering/). Conformational clustering was based on the coordinates of side chains belonging to residues W354 6.58 , R355 6.59 , P356 ECL3 , E357 ECL3 , K359 ECL3 , I360 ECL3 , A361 ECL3 and E362 ECL3 . A total of 10 clusters was generated with a root mean standard deviation cut-off value of 3 Å and a representative structure with a low distributed optimized potential energy score from the four most-populated ensembles was extracted and prepared for molecular dynamics simulations.
A similar approach was employed for clustering the modelled RAMP1 C terminus (residues T144-V148): the original PLOP-generated conformation was combined with each of the 4 initially selected ECL3 conformations, whereas a highly distinct RAMP1 C-terminus orientation was arbitrarily combined with ECL3 conformation number 1. Molecular dynamics simulations. A total of seven systems was prepared for molecular dynamics simulations with the CHARMM36 force field 53 ( Supplementary Table 6 ) using a multistep procedure that combines Python HTMD 54 and tool command language scripts. Hydrogen atoms were first added by means of pdb2pqr 55 and propka 56 software (considering a simulated pH of 7.0); the protonation of titratable side chains was checked by visual inspection. CLR and RAMP1 were embedded in a square 116 Å × 116 Å 1-palmitoyl-2-oleyl-sn-glycerol-3-phospho-choline (POPC) bilayer (previously built using the VMD Membrane Builder plugin 1.1: http://www.ks.uiuc.edu/Research/vmd/plugins/membrane/) through an insertion method 57 . More precisely, the opportune receptor orientation was obtained by superposing CLR coordinates on the CTR structure retrieved from the OPM database 58 . Lipids overlapping the receptor transmembranedomain bundle and RAMP1 were removed and TIP3P water molecules 59 To evaluate the influence exerted by RAMP1 on the CGRP-CLR complex, two simplified systems were embedded in 96 Å × 96 Å POPC bilayers and solvated as described above: one was composed of CLR-CGRP-RAMP1 and the C terminus (residues N371 G -L394 G ) of the G-protein α-subunit (CLR-CGRP-RAMP1-Gα(371-394)); the other was formed by CLR-CGRP and the C terminus of the Gα-subunit (CLR-CGRP-Gα(371-394)). The original PLOP-generated conformations of CLR and RAMP1 were used. Systems equilibration and molecular dynamics settings. The molecular dynamics engine ACEMD 60 was used for both the equilibration and productive simulations. Equilibration was achieved in isothermal-isobaric conditions (NPT) using the Berendsen barostat 61 (target pressure 1 atm) and the Langevin thermostat 62 (target temperature 300 K) with a low damping of 1 ps −1 . A three-stage procedure was performed (integration time-step of 2 fs): first, clashes between protein and lipid atoms were reduced through 2,500 conjugate-gradient minimization steps, then a 2-ns-long molecular dynamics simulation was run with a positional constraint of 1 kcal mol −1 Å −2 on protein and lipid phosphorus atoms. During the second stage, 40 ns of simulation was performed, constraining only the protein atoms, whereas in the last equilibration stage, positional constraints were applied only to the protein backbone alpha carbons, for a further 5 ns.
Supplementary Table 6 summarizes all the simulations performed. Trajectories were computed with an integration time-step of 4 fs in the canonical ensemble (NVT) at 300 K, using a thermostat damping of 0.1 ps −1 and the M-SHAKE algorithm 63 to constrain the bond lengths involving hydrogen atoms. The cut-off distance for electrostatic interactions was set at 9 Å, with a switching function applied beyond 7.5 Å. Long-range Coulomb interactions were handled using the particle mesh Ewald summation method (PME) 64 by setting the mesh spacing to 1.0 Å. Molecular dynamics analysis. Atomic contacts, hydrogen bonds and root mean square fluctuation (RMSF) were computed using VMD 65 . A contact was considered productive if the distance between two atoms was smaller than 3.5 Å. For hydrogenbond detection, a donor-acceptor distance of 3 Å and an angle value of 160° were set as geometrical cut-offs. The hydrogen-bond persistence is defined as the number of frames in which the hydrogen bond is formed, divided by the total number of frames × 100. The RAMP1 influence on van der Waals contacts and hydrogen bonds was evaluated by computing the numerical difference between the total numbers of contacts or hydrogen bonds between each CLR and CGRP side chain during the simulations in the presence and absence of RAMP1. Reporting Summary. Further information on research design is available in the Nature Research Reporting Summary linked to this paper. Data availability. All relevant data are available from the authors and/or included in the manuscript or Supplementary Information. Atomic coordinates and the cryo-EM density map have been deposited in the Protein Data Bank under accession number 6E3Y and the Electron Microscopy Data Bank, entry EMD-8978.
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Extended Data Fig. 1 | Amino acid sequences of the CGRP peptide, CLR and RAMP1 constructs used for determination of structure. The sequences are annotated to denote the location of the haemagglutinin (HA) signal sequence (red highlight), 3C cleavage sites (grey highlight), Flag (dark olive-green highlight) and His tags (purple highlight). The substituted sequences of the native proteins are listed above the construct sequences and highlighted in blue. Transmembrane helical domains in CLR and RAMP1 are boxed and highlighted in green. Segments of the proteins that were not resolved in the cryo-EM map are highlighted in yellow. Amino acids for which backbone density was present but there was limited side-chain density were stubbed in the model; these are shown in bold red in the sequences.
Extended Data Fig. 7 | RAMP1 makes extensive stable interactions with CLR. a, Hydrogen bonds between RAMP1 and CLR during molecular dynamics simulations (6.4 μs). The total persistence is plotted onto the experimental structure according to a rainbow colour scale, with residues that are never involved in dark blue and residues that are highly involved in red. The receptor is shown as a bulky ribbon, RAMP1 as a thin coloured ribbon and the peptide as a thin white ribbon. Key side chains are shown, but for intermittent hydrogen bonds the rotameric state has been modified to show an interaction. Residues forming an interaction network are labelled with the same colour. Left, overall topology of the system. Right top, magnified view of the upper portion of the CLR transmembrane domain and ECD; right bottom, view rotated by 90° on the z axis. Hydrogen bonds involved in the RAMP1-CLR interaction, R112 R -E47 ECD and D113 R -T288 ECL2 /H289 ECL2 are notable because they link the transmembrane domain to the ECD, and for stabilizing ECL2. Other hydrogen bonds implicated in stabilizing the CLR and RAMP1 ECD interaction include S107 R -E47 ECD , R102 R -D55 ECD , H97 R -Q50 ECD , D90 R -Y49 ECD , D71 R -R38 ECD and E29 R -R119 ECD . Quantitative data on the persistence of hydrogen bonds during the simulations are reported in Supplementary Table 2 . b, Contacts between RAMP1 and CLR during simulations (6.4 μs). The total persistence of a residue side chain is plotted onto the experimental structure according to a cyan-maroon colour scale, with residues that are never involved in cyan and residues that are highly involved in maroon. The peptide (italics, dashed line) is depicted as a thin ribbon, whereas the receptor (solid line) is shown as a bulky ribbon and transparent surface. Left, overall topology of the system. Top right, the most-persistent interactions involving RAMP residues and the CLR ECD, W59 R , I63 R , Y66 R , H97 R and I106 R help to anchor αH3 and the C-terminal RAMP1 regions of αH2 to (residues M42 ECD , T43 ECD , Y46 ECD , Y49 ECD , Q50 ECD and M53 ECD of the CLR ECD). Bottom right, the most-persistent hydrophobic interactions between the transmembrane domains of RAMP1 and CLR, namely I123 R , P126 R , T130 R , T134 R and V137 R (plus S141 R ) help to anchor the RAMP transmembrane helix to CLR (TM3-TM5; CLR residues Y277 ECL2 , H289 ECL2 , A300 5.45 , I235 3.52 , F262 4.52 , L258 4.48 and W254 4.44 ). Fig. 9 | CGRP makes extensive stable interactions with CLR. a-d, Distances between CGRP and CLR residues relevant to key hydrogen bonds. The x axis denotes sampling time for the 16 merged molecular dynamics replicas of the whole system (each replica is separated by a vertical dashed line). a, Distance between the peptide Asp3 carboxylic carbon and receptor R355 6.59 guanidinium carbon. b, Distance between the peptide Thr6 side-chain oxygen atom and the receptor H295 5.40 sidechain nitrogen atoms (for each frame, the closest nitrogen to Thr6 was considered). c, Distance between the peptide Arg11 guanidinium carbon and the receptor D366 7.39 carboxylic carbon. d, Distance between peptide Arg18 guanidinium carbon and receptor D287 ECL2 carboxylic carbon. In most cases, the distances corresponding to hydrogen-bond formation are slightly longer than the standard 2.8 Å. e, Hydrogen bonds between CGRP and CLR during molecular dynamics simulations (6.4 μs). The total persistence of a residue side chain is plotted onto the experimental structure according to a rainbow colour scale, with residues that are never involved in blue and residues that are highly involved in red. The peptide (italics, dashed line) is depicted as thin ribbon, whereas the receptor (solid line) is shown as bulky ribbon. Key side chains are shown, but for intermittent hydrogen bonds, the rotameric state has been modified to show an interaction. Residues forming an interaction network are labelled with the same colour. Bottom, hydrogen bonds between the CGRP N terminus and the transmembrane bundle of CLR. Top, hydrogen bonds between the CGRP C terminus and the ECD of CLR; quantitative data on the persistence of hydrogen bonds during the simulations are reported in Supplementary Table 3 . f, Contacts between CGRP and CLR-RAMP1 during molecular dynamics simulations (6.4 μs). The total persistence of a residue side chain is plotted onto the experimental structure according to a cyan-maroon colour scale, with residues that are never involved in cyan and residues that are highly involved in maroon. The peptide (italics, dashed line) is depicted as a thin ribbon, while the receptor (solid line) is shown as a bulky ribbon and transparent surface. Left, contacts between the N terminus of CGRP and the transmembrane bundle of the CLR: highly persistent hydrophobic interactions characterize peptide residues Leu12, Leu16, His10 and receptor residues L195 2.68 , A138 1.36 and H295 5.40 . Right, contacts between the C terminus of CGRP and the ECD of CLR; highly persistent contacts characterize peptide residues Val32, Thr30, Phe37 and receptor residues Q93 ECD and W72 ECD . RAMP1 residues F83 R , W84 R are mainly engaged by CGRP residue Phe37.
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